Predictions
Drägerwerk AG & Co. KGaA VZO
Start price
Target price
Perf. (%)
€49.15
01.06.22
01.06.22
-
01.06.23
01.06.23
-2.34%
11.06.22
11.06.22
Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected
Drägerwerk AG & Co. KGaA ST
Start price
Target price
Perf. (%)
€42.25
01.06.22
01.06.22
-
01.06.23
01.06.23
-0.47%
11.06.22
11.06.22
Fair valuation
Top 10 in its market
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Affimed N.V.
Start price
Target price
Perf. (%)
€4.75
11.04.22
11.04.22
-
11.04.23
11.04.23
-41.07%
08.06.22
08.06.22
Could be worthwhile Investment >10% per year
Geratherm Medical AG
Start price
Target price
Perf. (%)
€9.46
03.10.21
03.10.21
-
03.10.22
03.10.22
-10.78%
04.06.22
04.06.22
Could be very worthwhile Investment >20% year
Vita 34 AG
Start price
Target price
Perf. (%)
€11.05
18.05.22
18.05.22
-
18.05.23
18.05.23
-0.45%
28.05.22
28.05.22
Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
Biofrontera AG
Start price
Target price
Perf. (%)
€1.16
18.05.22
18.05.22
-
18.05.23
18.05.23
2.59%
28.05.22
28.05.22
Could be very worthwhile Investment >20% year
Undervalued
Drägerwerk AG & Co. KGaA VZO
Start price
Target price
Perf. (%)
€75.60
26.05.21
26.05.21
€82.00
26.05.22
26.05.22
-36.11%
27.05.22
27.05.22
Drägerwerk AG & Co. KGaA VZO
Start price
Target price
Perf. (%)
€74.55
07.05.21
07.05.21
€60.00
07.05.22
07.05.22
-37.42%
08.05.22
08.05.22
Higher EBIT margin than peer group
Probably not worthwhile Investment
Low dividend yield expected
Below average Management
Eckert & Ziegler Strahlen- und Medizintechnik AG
Start price
Target price
Perf. (%)
€81.20
03.05.21
03.05.21
€75.00
03.05.22
03.05.22
-41.82%
04.05.22
04.05.22
Could be worthwhile Investment >10% per year
Stratec SE
Start price
Target price
Perf. (%)
€116.60
03.03.21
03.03.21
€165.00
03.10.22
03.10.22
3.43%
06.04.22
06.04.22
Could be worthwhile Investment >10% per year
Mediclin AG
Start price
Target price
Perf. (%)
€3.32
07.03.22
07.03.22
-
07.03.23
07.03.23
0.60%
19.03.22
19.03.22
EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
Medigene AG
Start price
Target price
Perf. (%)
€3.90
02.07.21
02.07.21
-
02.07.22
02.07.22
-20.90%
09.03.22
09.03.22
Innovative
Dependend from some customers or products
Higher risks for its business
Drägerwerk AG & Co. KGaA VZO
Start price
Target price
Perf. (%)
€61.80
08.03.21
08.03.21
-
08.03.22
08.03.22
-21.91%
09.03.22
09.03.22
Drägerwerk AG & Co. KGaA ST
Start price
Target price
Perf. (%)
€61.80
08.03.21
08.03.21
-
08.03.22
08.03.22
-26.29%
09.03.22
09.03.22
Medigene AG
Start price
Target price
Perf. (%)
€3.71
22.02.22
22.02.22
€5.00
22.02.23
22.02.23
18.89%
23.02.22
23.02.22
Could be very worthwhile Investment >20% year
Very capable Management
Good culture
Little innovation
Vita 34 AG
Start price
Target price
Perf. (%)
€15.55
21.02.21
21.02.21
-
21.02.22
21.02.22
-25.08%
22.02.22
22.02.22
Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
Formycon AG
Start price
Target price
Perf. (%)
€67.40
07.02.21
07.02.21
€80.00
07.02.22
07.02.22
-20.03%
08.02.22
08.02.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High valuation
Low dividend yield expected
MPH Health Care AG
Start price
Target price
Perf. (%)
€26.00
16.05.21
16.05.21
€40.00
16.05.22
16.05.22
-5.77%
29.01.22
29.01.22
Could be very worthwhile Investment >20% year
Undervalued
Future proof or reliable business model
Significant cyclical dependencies
Drägerwerk AG & Co. KGaA ST
Start price
Target price
Perf. (%)
€67.80
23.01.21
23.01.21
€88.00
23.01.22
23.01.22
-26.99%
24.01.22
24.01.22
Fair valuation
Top 10 in its market
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Drägerwerk AG & Co. KGaA VZO
Start price
Target price
Perf. (%)
€71.80
23.01.21
23.01.21
€88.00
23.01.22
23.01.22
-30.36%
24.01.22
24.01.22
Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected
Eckert & Ziegler Strahlen- und Medizintechnik AG
Start price
Target price
Perf. (%)
€123.30
17.08.21
17.08.21
-
17.08.22
17.08.22
-27.01%
12.01.22
12.01.22
Mediclin AG
Start price
Target price
Perf. (%)
€4.36
10.01.21
10.01.21
€6.00
10.01.22
10.01.22
-15.14%
11.01.22
11.01.22
EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model